News | October 30, 2023
Dr Reddy's Q2 FY24 PAT jumps 33% to Rs 1,480 Cr
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
The companies plan to start a pivotal Phase 3 trial in the coming months
RHTC will address a long-standing healthcare access issue for all the local population
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Investment is additive to KKR’s existing health care growth strategy
Subscribe To Our Newsletter & Stay Updated
